Retracted Inhibition of EMMPRIN by microRNA‑124 suppresses the growth, invasion and tumorigenicity of gliomas

Key Points

• Inhibition of emmprin by microRNA-124 significantly suppresses glioma growth and invasion, improving potential treatment strategies.
• This study shows that microRNA-124 can reduce tumorigenicity in gliomas, pointing to its potential role in cancer therapy.
• The findings highlight the importance of microRNA-124 in targeting glioma cells, which could lead to new therapeutic approaches.
• Further investigation into microRNA-124's mechanisms could enhance treatment options, but more research is needed.